Anika Therapeutics
ANIK
#8888
Rank
HK$1.53 B
Marketcap
HK$115.03
Share price
-2.27%
Change (1 day)
27.43%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): -HK$6.19

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$6.19. In 2025 the company made an earnings per share (EPS) of -HK$5.96 an increase over its 2024 EPS that were of -HK$30.19.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$6.193.83%
2025-HK$5.96-80.26%
2024-HK$30.19-31.86%
2023-HK$44.30448.54%
2022-HK$8.08-455.17%
2021HK$2.27-115.68%
2020-HK$14.51-195.85%
2019HK$15.1348.46%
2018HK$10.19-40.37%
2017HK$17.09-1.8%
2016HK$17.417.77%
2015HK$16.15-21.37%
2014HK$20.5474.67%
2013HK$11.7670.45%
2012HK$6.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.49-1,205.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$29.33-573.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
HK$68.45-1,205.06%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
-HK$3.37-45.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$22.90-469.62%๐Ÿ‡บ๐Ÿ‡ธ USA